Today's K2 Understanding Is The
Result Of Our Efforts
A commitment to clinical validation is no small endeavor. While Vitamin K2 is now a rising star in the natural products industry, this star has been burning for more than a decade, driven solely by NattoPharma.
Our founders identified a problem and began talks with some of the most respected researchers to find a solution. Population-based observational studies were the beginning – great minds examining what could likely be causing one group of people to have superior bone and heart health. But that is where the real work began.
Proving a mechanism delivers a health benefit and confirming safe and effective dosages takes time. We did that — more than 20 times, with more trials currently underway. And we did it, providing MenaQ7® Vitamin K2 as the actual source material. So while we were demonstrating the importance of K2, we were also verifying our brand’s efficacy.
We are the undisputed leader in clinical understanding and science. Our unprecedented and ongoing investment in groundbreaking research has allowed us to identify novel health benefits and open up new market opportunities for our partners.
And the work is not done, not by a long shot. But that is why you want to be our partner: our unwavering commitment to understanding what makes K2 a global health game-changer and ensuring we — and you — have the evidence to back that up.
Regulatory Compliance Is Key: Protecting Our Collective Interests
It should go without saying, but we want you to be understand our commitment to strict compliance with each country’s legal and regulatory requirements to sell our products. (You’d like to think that goes without saying, but you should have this assurance from every supplier. Do you?)
With our science as the foundation, we are the only Vitamin K2 company that can pursue – and earn – regulatory approval of key health claims. And we actively seek certifications from independent groups that differentiate our brand over others.
NattoPharma aggressively pursues opportunities in new markets as we continually add new claims, products, applications, and usages. We have product registrations or authorizations in key markets worldwide, including countries in Europe, North & South America, Australia, Middle East, Asia Major, and Africa.
Wherever you are, we have you covered.
PATENTS & IP Our Competitive Advantage Is Your Added Value
NattoPharma actively pursues patents in key markets and countries as part of our overall intellectual property strategy to enhance our already robust patent portfolio, including six patent families.
We have converted our cutting-edge research into proprietary method of use patents that support and provide exclusivity to efficacy claims and pending process patents on the manufacturing synthesis of our nature-identical product. These efforts add significant value to your products, providing you points of clear differentiation in the market.
Our continued focus on IPR not only builds our competitive advantage, but those patents provide you enhanced value to address health benefits and market segments.
The team at Nattopharma are true
leaders in the Vitamin K2 field --
the only company sponsoring
ongoing clinical trials.
Craig Fallshaw, CEO, Complementary Medicines Group